Cvs stock forecast 2025

With a high three-year median payout ratio of 66% (implying that 34% of the profits are retained), most of CVS Health's profits are being paid to shareholders, which explains the company's shrinking earnings. The business is only left with a small pool of capital to reinvest - A vicious cycle that doesn't benefit the company in the long-run. Our risks dashboard should have the 3 risks we have identified for CVS Health. Members of Congress have traded $CVS stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales. The CVS stock forecast 2025 remains supported by stable dividend distributions, appealing to income‑focused investors within the defensive equity segment.